Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel PTK-related technology from Genentech and collaborators

Feb. 5, 1998

Potent SK(Ca) channel blocker prepared by European university researchers

Feb. 4, 1998

Zeneca receives patent protection for new Diprivan formulation

Feb. 4, 1998

Neuroprotective activity described for CoCensys neurosteroid

Feb. 4, 1998

Neuroprotective effects of IL-1ra

Feb. 4, 1998

StressGen licenses heat shock transcription factors

Feb. 4, 1998

New targets for stroke: neurotrophic growth factors

Feb. 4, 1998

Crescendo and Alza to collaborate on chronic pain product

Feb. 3, 1998

Tasmar cleared by FDA

Feb. 3, 1998

Anxiolytic candidate with favorable pharmacokinetic properties developed at Warner-Lambert

Feb. 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...